AFP and hepatocellular carcinoma: These results show that miRNAs may be a suitable target for the development of the next generation of biomarkers for early diagnostic HCC, and miRNA panels or combined miRNAs and proteins such as AFP may provide a high diagnostic accuracy of HCC as compared with single miRNA.